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Abstract
Musculoskeletal soft tissue injuries are complex phenotypes with genetics being one of
many proposed risk factors. Case-control association studies using the candidate gene
approach have predominately been used to identify risk loci for these injuries. However, the
ability to identify all risk conferring variants using this approach alone is unlikely. Therefore,
this study aimed to further define the genetic profile of these injuries using an integrated
omics approach involving whole exome sequencing and a customised analyses pipeline.
The exomes of ten exemplar asymptomatic controls and ten exemplar cases with Achilles
tendinopathy were individually sequenced using a platform that included the coverage of
the untranslated regions and miRBase miRNA genes. Approximately 200 000 variants were
identified in the sequenced samples. Previous research was used to guide a targeted analy-
sis of the genes encoding the tenascin-C (TNC) glycoprotein and the α1 chain of type XXVII
collagen (COL27A1) located on chromosome 9. Selection of variants within these genes
were; however, not predetermined but based on a tiered filtering strategy. Four variants in
TNC (rs1061494, rs1138545, rs2104772 and rs1061495) and three variants in the upstream
COL27A1 gene (rs2567706, rs2241671 and rs2567705) were genotyped in larger Achilles
tendinopathy and anterior cruciate ligament (ACL) rupture sample groups. The CC genotype
of TNC rs1061494 (C/T) was associated with the risk of Achilles tendinopathy (p = 0.018,
OR: 2.5 95% CI: 1.2–5.1). Furthermore, the AA genotype of the TNC rs2104772 (A/T) vari-
ant was significantly associated with ACL ruptures in the female subgroup (p = 0.035, OR:
2.3 95% CI: 1.1–5.5). An inferred haplotype in the TNC gene was also associated with the
risk of Achilles tendinopathy. These results provide a proof of concept for the use of a cus-
tomised pipeline for the exploration of a larger genomic dataset. This approach, using previ-
ous research to guide a targeted analysis of the data has generated new genetic signatures
in the biology of musculoskeletal soft tissue injuries.
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Introduction
Musculoskeletal soft tissue injury is an encompassing term used to describe pathologies affect-
ing tendons, ligaments and skeletal muscles [1]. These phenotypes commonly present at clini-
cal practices, with patients reporting impaired sporting performance and decreased functional
capacity [1]. The underlying biological origin of these injuries is complex and still highly
debated. However, several risk factors have been proposed, including a person’s genetic profile
(reviewed by September et al. 2016 and Rahim et al. 2016) [2,3].
To date, several DNA sequence variants have been associated with susceptibility for overuse
and acute injuries such as Achilles tendinopathy, tennis elbow, rotator cuff injuries and ACL
ruptures [2–7]. It is interesting to note that although tendons and ligaments are anatomically
distinct structures with different primary functions, they are similar in molecular composition
and share several morphological features [8]. It is therefore not surprising that there are simi-
larities (shared) and differences (unique) in the loci implicated in these clinically distinct mus-
culoskeletal injuries [2].
These previous studies have employed the use of candidate gene, case-control genetic asso-
ciation studies to test the association of predominantly singleton variants with the risk of
injury susceptibility. This approach is hypothesis driven, whereby the candidate genes and the
investigated variants are selected based on known biological function and an a priori hypothe-
sis that the gene product is involved in injury development [9]. Although this method has
served as the basic investigative strategy for much of the research within the field, it has an
important limitation. Our current knowledge of the biological mechanisms underlying muscu-
loskeletal soft tissue injuries is limited. Consequently, only a select number of genes and vari-
ants have been investigated. Therefore, the ability to identify all risk conferring loci within the
genome, contributing only modestly to injury susceptibility, is limited using this approach
alone.
Few studies have adopted next generation technologies such as whole exome sequencing
(WES) or genome wide association studies (GWAS) to define the susceptibility profile of mus-
culoskeletal soft tissue injuries. One familial study including fraternal twins, both of whom
had sustained ACL ruptures, identified 11 plausible risk-conferring variants that may contrib-
ute to ACL ruptures of a non-contact nature [10]. Baird et al. (2014) [11] and Baker et al.
(2017) [12] identified alternate loci associated with the risk of cruciate ligament ruptures in the
domestic dog. Furthermore, two single nucleotide polymorphisms were found to significantly
associate with the risk of rotator cuff tears in a GWAS by Tashjian et al. (2017) [13]. Con-
versely, a GWAS conducted by Kim et al. (2017) [14] was unable to identify any risk conferring
variants associated with either Achilles tendinopathy or ACL ruptures using a false discovery
rate less than 5%. The slow uptake of high throughput technologies in the study of musculo-
skeletal soft tissue injuries may be explained by the expense associated with such an approach,
from initial sample preparation through to the sequencing process and bioinformatic analysis
of the generated data. This is particularly true in complex, multifactorial conditions in which
large sample sizes are required in order to achieve sufficient power to detect statistically signifi-
cant associations using traditional statistical methods [15]. A novel approach is therefore
required to facilitate the interrogation of the genome and assist in refining the biological motifs
underpinning musculoskeletal soft tissue injuries. Whole genome sequencing of well pheno-
typed participants provides the most comprehensive variant coverage, allowing for in-depth
analyses of the genetic basis of disease [16]. However, the associated cost and complexity of
data analysis has limited its accessibility. Since many disease-related variants have been identi-
fied in protein encoding regions [15,17] sequencing only the exome provides a cost effective
alternative to whole genome sequencing.
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Therefore, the primary aim of this study was to apply a whole exome sequencing approach
using exemplar controls and cases, to further assist in identifying genetic markers predisposing
to chronic Achilles tendinopathy. The secondary aim involved determining whether any vari-
ants found to be associated with chronic Achilles tendinopathy were similarly associated with
the risk of acute ACL ruptures. This was based on the a priori hypothesis that functional vari-
ants within genes encoding components of the extracellular matrix (ECM) may similarly
influence the integrity of both tendons and ligaments. Furthermore, previous research has
implicated several genetic loci predisposing for chronic phenotypes in the risk profile of acute
musculoskeletal soft tissue injuries (reviewed Rahim et al. 2016) [2]. Therefore, to address the
aims of the study, a customised WES analysis pipeline was developed and variants within tar-
geted genomic regions were prioritised for further interrogation in larger, independent injury
groups using a case-control genetic association study approach.
Material and methods
Participants
Approval of this study was obtained from the Research Ethics Committee of the Faculty of
Health Sciences within the University of Cape Town (HREC ref: 176/2015 and 224/2013).
Existing databases of individuals previously recruited for ongoing research were used for this
study. Two independent South African sample groups were selected for further downstream
applications. The first, a South African chronic Achilles tendinopathy group, consisted of
healthy control participants (CON, n = 165) and individuals with clinically diagnosed Achilles
tendinopathy (TEN, n = 123). The second group included control participants (CON, n = 232)
and individuals with surgically diagnosed anterior cruciate ligament ruptures (ACL, n = 234).
Approximately 60% of participants with ACL ruptures reported a noncontact mechanism of
injury and were additionally analysed as a separate subgroup (NON, n = 135). The participants
in both groups were of self-reported European Caucasian ancestry. Experienced sports physi-
cians or orthopaedic surgeons diagnosed all injuries. Achilles tendinopathy was confirmed
using inclusion and exclusion criteria as previously described [18], whereas ACL ruptures
were confirmed using magnetic resonance imaging (MRI), arthroscopy and during recon-
structive surgery. Control participants were recruited from various sports clubs and gyms
around Cape Town while the case participants were recruited from the Sports Science Ortho-
paedic Clinic at the Sports Science Institute of South Africa. All participants provided written
informed consent in accordance with the Declaration of Helsinki, and completed a question-
naire regarding their personal particulars, physical activity and medical history. Approximately
five mililitres of venous blood was previously obtained from each participant through the veni-
puncture of a forearm vein and collected in a vacuum ethylenediaminetetraacetic acid tube as
previously described [19–21]. Blood samples were stored at -20˚C until total DNA extraction
was performed, using the protocol as described by Lahiri and Nurnberger (1991) [22] and later
modified by Mokone et al. (2005) [19].
Whole exome sequencing
Chronic Achilles tendinopathy was selected as the phenotypic model of injury for the initial
exome sequencing project. The previously recruited Achilles tendinopathy group has been
well characterised and was therefore considered the most appropriate phenotype for further
interrogation into the genetic basis of disease [18,19]. From this original group, a subset of
exemplar asymptomatic controls (n = 10, 6 males) and exemplar cases with chronic Achilles
tendinopathy (n = 10, 6 males), representing divergent extremes of the phenotype spectrum
were selected for WES. All cases reported the early onset of initial symptoms (35 years of age
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or younger), suffered chronic bilateral mid-portion Achilles tendinopathy and/or reported
multiple Achilles tendon injuries (confirmed by a sports physician). The selected controls were
unrelated, older than 47 years of age at time of recruitment, physically active and reported no
previous tendon or ligament injuries. Genomic DNA extracted from each of these 20 partici-
pants was prepared according to the requirements of the WES service provider (Otogenetics,
United States). All samples passed Otogenetics’ quality screening.
Individual samples were sequenced at paired ends on the Illumina HiSeq 2000/2500 plat-
form at 30X coverage using the Agilent V5+UTR (71Mbp) capture kit (Agilent Technologies,
Santa Clara, United States). The average read length on this platform is 106 base pairs. The
Agilent V5+UTR capture kit targets all exonic and untranslated regions including miRBase
miRNA genes. Sequencing read quality control was performed using FastQC (https://www.
bioinformatics.babraham.ac.uk/projects/fastqc/). All samples passed pre- and post-alignment
quality control with no trimming of reads required.
Forward and reverse sequencing reads for each sample were aligned to the hg19 (GRCh37)
human genome build using Novoalign (Novocraft Technologies, Selangor, Malaysia). Samples
which demonstrated insufficient coverage on the first sequencing run, were sequenced again
on the same platform. For these samples, the sequencing alignment map (SAM) files were
merged using Samtools ‘reheader’ and Picard ‘MergeSamFiles ‘ [23]. Samtools was used to
convert SAM files to BAM files (binary version of SAM files) for condensed storage and fur-
ther analysis. Duplicate reads were removed using Picard (https://broadinstitute.github.io/
picard/). The Genome Analysis ToolKit (GATK) was then used for insertion-deletion realign-
ment, base quality score recalibration and variant calling (https://software.broadinstitute.org/
gatk/). Quality evaluation was performed using the GATK hard-filtering guidelines to produce
a set of high-likelihood variants for each exome. The resulting variant call format (vcf) file was
annotated using the web version of ANNOVAR (wANNOVAR) [24].
Variant filtering
A total of 204 807 variants meeting the quality score threshold were called in the 20 samples
included in this study. Variants where genotype calls were missing in two or more samples in
either of the control or case groups were excluded due to sample size concerns (n = 1916). Vari-
ants called with more than two alleles (multi-allelic loci, n = 3 435) were extracted from the
dataset as they did not form part of the focus of this initial study. These variants were stored for
future analyses. Since tendinopathy is a common, multifactorial condition with no clear inheri-
tance pattern, variants were not filtered on inheritance pattern. Allele frequencies were calculated
in the sequenced control and case groups for each variant. An allele frequency difference of
�30% was selected as a cut-off to identify variants of interest for further analysis. Hereafter, this
frequency difference is referred to as the “allele frequency difference threshold”. This conserva-
tive threshold was selected based on the previous observation that an allele or genotype fre-
quency difference of between 10–20% between control and case groups in genetic association
studies usually indicated a significant association using traditional statistical methods. Further-
more, acknowledging the fact that (i) the biology of Achilles tendinopathy is multifactorial, (ii) a
certain number of variants which are associated with predisposition may likely be common to
both controls and cases and (iii) only a small number of samples were sequenced (n = 20), a 30%
allele frequency difference was proposed as a conservative indicator of potential significance.
Targeted gene analysis and variant prioritisation
To address the aims of this study, all variants identified by WES were filtered for those which
met the allele frequency difference threshold. Given the limitations of the previous candidate
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variant approach, all variants located within genes implicated in genetic association studies
were extracted and screened to identify potential risk modifying effects which were previously
missed using the former approach. In addition, variants which mapped to any of the 35 genes
identified as strong tendinopathy candidate genes in a previously published study using the
BioOntological Relationship Graph (BORG) semantic database were also extracted for further
interrogation [25].
To illustrate the proof of concept of using WES together with a targeted gene approach
to define the predisposing genomic intervals for injury, the COL27A1 (chr9q32) and TNC
(chr9q33.1) genes which were previously associated with injury risk [18,26], were prioritised
for further interrogation. All variants that localised to these genes and met the allele frequency
difference threshold were extracted, mapped and functionally annotated using the National
Center for Biotechnology Information (NCBI) database (https://www.ncbi.nlm.nih.gov/), and
Ensembl (https://www.ensembl.org/index.html). Tagged SNPs were identified using the 1000
Genomes Project data (phase-3) [27] and the WES allele frequencies. To confirm pairwise
linkage, putative tagged loci were genotyped in 10% of all samples in the Achilles tendinopathy
group. All variants prioritised in the WES study were verified by Sanger sequencing (Inqaba
Biotechnical Industries, Pretoria, South Africa) prior to genotyping. An illustrative overview of
the customised filtering strategy is provided (Fig 1).
Variants were selected for genotyping in the larger Achilles tendinopathy and ACL rupture
sample groups based on likely functional impact annotations, coding effects (splice, nonsense,
missense variations), and linkage disequilibrium (Table 1). The three TNC variants prioritised
for investigation were rs1061494 (T/C; exon 4), rs2104772 (A/T; exon 17) and rs1061495 (T/C;
exon 18). The three COL27A1 variants prioritised for investigation were rs2567706 (A/G; exon
3), rs2241671 (G/A; exon 3), and rs2567705 (A/T; exon 3). The rs1061495 (TNC) variant dem-
onstrated an allele frequency difference of only 25% between the sequenced controls and cases.
However, due to its location in relation to i) previously associated variants or ii) the newly
identified WES candidates, in addition to its predicted coding effect, this variant was included
in the analysis. Similarly, the TNC rs1138545 variant did not meet the allele frequency differ-
ence threshold but has previously been associated with degenerative rotator cuff tears and was
therefore prioritised for investigation [5].
Case-control genetic association analysis
The independent ACL sample group was introduced at this stage of the study, to assess
whether the WES prioritised variants were associated with musculoskeletal soft tissue inju-
ries other than that of Achilles tendinopathy. All case-control genetic association analyses
were conducted in accordance with the strengthening the report of genetic association
studies (STREGA) statement for reporting the results of genetic association studies [28].
The QUANTO v1.2.4 program was used to calculate the statistical power based on the
respective sample sizes (http://biostats.usc.edu/software). All control and case participants
were genotyped for the selected variants within the TNC and COL27A1 genes using fluores-
cence-based Taqman single nucleotide polymorphism (SNP) genotyping assays (Applied
Biosystems, Foster City, California, USA). The CON and TEN samples in the Achilles tendi-
nopathy sample group were previously genotyped for the TNC rs2104772 variant and the
results presented by Saunders et al. 2012 [26]. With permission, these genotypes, in addition
to 30 extra Achilles tendinopathy cases and 34 controls genotyped in this current study,
were included for haplotype analysis. For quality control purposes, positive and DNA-free
control samples were included in each 96-well polymerase chain reaction (PCR) plate. Two
independent investigators confirmed genotype calls and all laboratory work was conducted
Defining the genetics of musculoskeletal soft tissue injuries using whole exome sequencing
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at the Division of Exercise Science & Sports Medicine within the University of Cape Town.
It must be noted that results are presented for all variants in the male and female combined
group, but only for those of significance in the independent sex groups in the ACL study
group.
Fig 1. Customised filtering strategy used to prioritise variants identified by whole exome sequencing for interrogation in injury sample groups.
Diagram describing the stepwise process of mining the data generated by whole exome sequencing using a customised tiered filtering strategy. An
exemplar application of the filtering strategy is presented, whereby variants within the TNC and COL27A1 genes were prioritised for genotyping. After
alignment and post-alignment processing and the removal of variants with missing genotype data or multiple alleles, a total of 199 456 variants were
identified across the 20 sequenced exomes. Step 1 involved extracting all variants identified by WES mapping to the candidate loci. Step 2 involved
mining for variants with an allele frequency difference of�30% between the sequenced controls and cases. Step 3 involved the functional annotation of
candidate variants using a several open, online bioinformatic resources. Linkage analysis using 1000 Genomes Project data (phase-3) was used to
identify tagged loci from selected candidate variants. All variants prioritised for genotyping were confirmed using Sanger sequencing in step 4. Step 5
involved genotyping candidate variants in the larger injury sample groups.
https://doi.org/10.1371/journal.pone.0205860.g001
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Statistical analysis
Statistical analysis was conducted using the R programming environment (https://www.r-
project.org/). Descriptive analyses of quantitative variables were represented as means and stan-
dard deviation (SD) while frequencies were determined for qualitative participant characteris-
tics. A one-way analysis of variance (ANOVA) test was used to examine the characteristic
differences amongst the sample groups and the possible genotype effects on age, height, weight,
body mass index (BMI) and sex. The genetics and SNPassoc packages were used to estimate
genotype and allele frequencies and exact Hardy-Weinberg equilibrium (HWE) probabilities
for the controls and cases in the two independent groups [29,30]. Several non-genetic parame-
ters were considered potential confounders and were corrected for in the logistic regression
models testing for the association of genotypes and alleles with musculoskeletal soft tissue inju-
ries. These confounding factors were equally weighted within the regression models and entered
by means of a forward method. The haplo.stats package was used to test for the association
between inferred haplotypes and the risk of injury [31]. The strength of association between the
inferred haplotypes and the phenotype is reflected by the score statistic (Haplo.score). Negative
values infer decreased risk, while positive scores infer increased risk. Only haplotypes with a
total frequency>5% were presented. Statistical significance was accepted when p<0.05. No
adjustments for multiple testing were made as it has been suggested that statistical corrections,
including Bonferroni, overcorrect for an inflated false positive rate and significantly reduce the
power in genetic association studies, in which linkage disequilibrium exists between loci [32].
Results
The average depth of coverage for all samples was 49X with 90% of target bases sequenced at a
coverage higher than 15X. A total of 199 456 variants meeting the quality score threshold were
called in the 20 sequenced samples.
Table 1. The TNC and COL27A1 variants prioritised for genotyping after exome sequencing and the application of a customised, tiered filtering strategy.
SNP ID Alleles MAF Chromosome position Variant location Coding effect AA change Allele difference (%)
Ref Alt
TNC variants
rs944510 C T 0.44 (T) 9: 117853022 Exon 2 SYN V-V 0.35
rs2992147 C T 0.44 (C) 9: 117849314 Exon 3 SYN V-V 0.35
rs1061494 C T 0.44 (C) 9: 117846580 Exon 4 NON-SYN Q-R 0.35
rs1138545 C T 0.18 (T) 9: 117835899 Exon 10 NON-SYN R-H 0.10
rs2104772 T A 0.42 (A) 9: 117808785 Exon 17 NON-SYN I-I 0.45
rs1061495 T C 0.26 (C) 9: 117804544 Exon 18 SYN T-T 0.25
COL27A1 variants
rs2567706 G A 0.27 (G) 9: 116930194 Exon 3 NON-SYN Q-R 0.30
rs2241671 G A 0.39 (A) 9: 116931099 Exon 3 NON-SYN A-T 0.30
rs2808770 C T 0.27 (C) 9: 116931445 Exon 3 NON-SYN I-T 0.30
rs2567705 T A 0.38 (T) 9: 116931666 Exon 3 NON-SYN I-F 0.30
rs2808771 T C 0.27 (T) 9: 116931737 Exon 3 SYN G-G 0.30
TNC: Gene encoding the tenascin-C glycoprotein; COL27A1:Gene encoding α1 chain of type XXVII collagen. SNP ID: dbSNP accession number. MAF: Minor allele
frequency according to European 1000 Genomes project data (phase-3), Chromosome Position: Chromosome location on the Human GRCh37.p13 Genome release.
Coding effect: SYN (synonymous), NON-SYN (non-synonymous). AA change: Amino acid substitution at locus. The allele frequency difference between exemplar
control and case groups reported in the WES data output as a percentage. V: Valine, Q: Glutamine, R: Arginine, H: Histidine, I: Isoleucine, L: Lysine, T: Threonine, A:
Alanine, F: Phenylalanine, G: Glycine.
https://doi.org/10.1371/journal.pone.0205860.t001
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A total of 4544 variants in 2127 genes met the allele frequency difference threshold. With
respect to the genes previously associated with Achilles tendinopathy using a candidate gene
approach, 338 variants were identified, 19 demonstrating allele frequency differences equal
to or above the 30% threshold (Fig 2). The rs2104772 (A/T) variant, within the previously
associated TNC gene [26], demonstrated the highest allele frequency difference between the
sequenced controls and cases (45%). Furthermore, 757 variants, 26 of which met the allele fre-
quency difference threshold, mapped to the 35 genes previously proposed as plausible candi-
date genes for tendinopathy risk using the BORG in silico approach (Fig 3) [25]. The heparan
sulfate proteoglycan 2 (HSPG2) gene on chromosome 1 was the locus with the greatest number
of variants (n = 74), 14 of which met the allele frequency difference threshold.
Three TNC variants identified by WES and meeting the allele frequency difference thresh-
old were in complete linkage disequilibrium with one another. Specifically, the T allele of
rs1061494 (C/T) corresponded to the T allele of the rs2992147 (T/C) and the C allele of
Fig 2. Distribution of variants identified by whole exome sequencing within genes previously associated with the
risk of musculoskeletal soft tissue injuries. Schematic diagram demonstrating the number and distribution of
variants identified through whole exome sequencing of ten exemplar controls and ten exemplar cases. (i) Total number
of variants identified across the 20 sequenced exomes. (ii) The autosomes numbered from 1–22, and the X gonosome.
The Y gonosome is not presented due to its size relative to the other chromosomes. A total of 32 variants were called
on the Y chromosome. (iii) Total number of variants identified mapping to each chromosome using WES. (iv) Genes
previously associated with risk of Achilles tendinopathy and other musculoskeletal soft tissue injuries mapping to the
respective chromosomes. (�) Asterix indicates genes specifically associated with Achilles tendinopathy. (v) Total
number of variants identified mapping to the respective genes with number of variants that meet the allele frequency
difference threshold in parentheses.
https://doi.org/10.1371/journal.pone.0205860.g002
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rs944510 (C/T). The D’ measure and coefficient of correlation (r2) was 1.000 between all three
variants respectively [27]. The remaining WES prioritised variants were not tagged loci and
for that reason were genotyped in the larger sample groups. The participant characteristics of
the Achilles tendinopathy and ACL groups were previously described [18,21,33]. No genotype
effects on participant characteristics were noted for the investigated TNC variants (S1 Table).
The genotype and minor allele frequency distributions of the TNC variants in the control and
case samples for the two independent sample groups, together with the test scores for HWE
are additionally provided (S2 and S3 Tables).
No significant differences in the genotype and allele frequency distributions were noted
between the CON and TEN groups in the Achilles tendinopathy sample group for two of the
three genotyped variants; rs1138545 (C/T) CON vs. TEN (p = 0.437); rs1061495 (T/C) CON
vs. TEN (p = 1.000) (S2 Table). A significant difference was however noted for rs1061494 (T/
C) between the control and case groups (p = 0.049). Specifically, the CC genotype was signifi-
cantly underrepresented in the CON group compared to the TEN group (CON: 13%, n = 18,
TEN: 24%, n = 20; p = 0.018, OR: 2.5 95%, CI: 1.2–5.1) (Fig 4A).
No significant differences in the genotype and allele frequency distributions were noted
between the CON group, ACL group and NON subgroup in the ACL injury sample group for
the genotyped variants; rs1061494 (T/C) CON vs. ACL (p = 0.917), CON vs. NON (p = 0.598);
Fig 3. Distribution of variants identified by whole exome sequencing within genes proposed as plausible
candidates for Achilles tendinopathy using the BioOntological Relationship Graph database. Schematic diagram
demonstrating the number and distribution of variants identified by WES mapping to the 35 genes identified as
plausible candidates for Achilles tendinopathy using BORG. (i) Total number of variants identified mapping to the 35
BORG candidate genes. (ii) The autosomes numbered from 1–22, and the X gonosome. (iii) Names of BORG
identified candidate genes. (iv) Total number of variants identified mapping to BORG identified genes candidates with
number of variants meeting the allele frequency difference threshold in parentheses.
https://doi.org/10.1371/journal.pone.0205860.g003
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rs1138545 (C/T) CON vs. ACL (p = 0.489), CON vs. NON (p = 0.356); rs2104772 (T/A) CON
vs. ACL (p = 0.846), CON vs. NON (p = 0.816) and rs1061495 (T/C) CON vs. ACL (p = 0.169),
CON vs. NON (p = 0.129), with the exception of the rs2104772 variant. The genotype fre-
quency distribution of rs2104772 (T/A) was significantly different between controls and cases
when only female participants were evaluated in the ACL sample group (p = 0.048), with the
AA genotype significantly underrepresented in the CON group (18%, n = 18) compared to the
group of cases (33%, n = 18, p = 0.035; OR: 2.3 95% CI: 1.1–5.5) (Fig 4D). Deviations from
HWE have been noted (S2 and S3 Tables). Haplotypes were inferred using the genotype data
from the four investigated TNC variants, rs1061494 (T/C), rs1138545 (C/T), rs2104772 (T/A)
and rs1061495 (T/C). No significant differences in the frequency distributions of the inferred
haplotypes were noted between the CON and TEN participants in the Achilles tendinopathy
sample group (Fig 5A). However, a significant frequency difference was noted for the TNC
T-T inferred haplotype, constructed from the rs1061494-rs2104772 variants in the Achilles
tendinopathy sample group. Specifically, the frequency distribution of the T-T inferred haplo-
type was significantly overrepresented in the CON group (30%, n = 40) compared to the TEN
group (22%, n = 17) (Dominant model: p = 0.032, Haplo.score: -2.146) (Fig 5B).
No significant differences in the frequency distribution of the inferred haplotypes con-
structed from the four investigated TNC variants were noted between the CON and ACL
groups and similarly between the CON group and NON subgroup when all participants were
Fig 4. Genotype frequency differences of the TNC rs1061494 and rs2104772 variants in the Achilles tendinopathy
and ACL rupture groups. Genotype frequency distribution of the TNC rs1061494 (C/T) variant in the (A) Achilles
tendinopathy sample group. Genotype frequency distributions of the TNC rs2104772 (A/T) variant in the (B) ACL
sample group, (C) male ACL subgroup and (D) female ACL subgroup. CON: Control participants; TEN: Cases with
Achilles tendinopathy; ACL: Cases with ACL ruptures; NON: Subgroup of cases reporting a non-contact mechanism
of ACL injury. Statistically significant differences in genotype frequency between the groups are depicted on the
graphs, with p-values adjusted for confounders including age and sex in the Achilles tendinopathy sample group and
age, sex and weight in the ACL rupture sample group. The number of participants in each group (n) is in parentheses.
https://doi.org/10.1371/journal.pone.0205860.g004
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analysed (p = 0.747, p = 0.600) (Figure A in S1 File). Similarly, the frequency distributions of
the inferred haplotypes constructed from the two variants associated with the risk of Achilles
tendinopathy (rs1061494-rs2104772) were not significantly different between the CON and
ACL groups (p = 0.945) and CON group and NON subgroup (p = 0.908) (Figure B in S1 File).
Furthermore, no significant differences in the distribution of the inferred haplotypes con-
structed from the four investigated variants were noted when male CON participants were
compared to male ACL and male NON participants (p = 0.735, p = 0.703) (Figure C in S1
File). The frequency of the haplotypes constructed from the two variants associated with the
risk of AT (rs1061494-rs2104772) were also similarly distributed between the CON and ACL
Fig 5. Frequency distribution of TNC haplotypes in the Achilles tendinopathy sample group. (A) Frequency
distribution of the inferred haplotypes constructed from the TNC rs1061494, rs1138545, rs2104772 and rs1061495
variants in the Achilles tendinopathy sample group. (B) Frequency distribution of the inferred haplotypes constructed
from the TNC rs1061494 and rs2104772 variants in the Achilles tendinopathy sample group. CON: Control
participants; TEN: Achilles tendinopathy cases. Statistically significant differences in haplotype frequency between the
groups are depicted on the graph, with p-values adjusted for age and sex. The number of participants (n) in each group
is in parentheses.
https://doi.org/10.1371/journal.pone.0205860.g005
Defining the genetics of musculoskeletal soft tissue injuries using whole exome sequencing
PLOS ONE | https://doi.org/10.1371/journal.pone.0205860 October 25, 2018 11 / 20
group (p = 0.730) and CON and NON subgroup (p = 0.836) when male participant were ana-
lysed independently (Figure D in S1 File).
Four of the WES identified COL27A1 variants meeting the allele frequency threshold were
in high linkage disequilibrium. Specifically, the A allele of rs2567706 (A/G) corresponded to
the G of rs2567707 (G/A), the T allele of rs2808770 (T/C) and the C allele of rs2808771 (C/T)
respectively. The D’ measures were reported at 1.000 and the coefficient of correlation ranged
between 0.900–1.000 for all pairwise comparisons [27]. The remaining WES identified variants
mapping to COL27A1 were in linkage equilibrium and for that reason were genotyped in the
larger sample groups. No genotype effects on participant characteristics were noted for the
investigated variants (S4 Table).
No significant differences in the genotype and allele frequency distributions were noted
between the CON and TEN participants in the Achilles tendinopathy sample group for all
three genotyped variants; rs2567706 (A/G) CON vs. TEN (p = 0.778); rs2241671 (G/A) CON
vs. TEN (p = 0.964); rs2567705 (A/T) CON vs. TEN (p = 0.626) (S5 Table). Similarly, no signif-
icant differences in the genotype and allele frequency distributions were noted between the
CON, ACL and NON participants in the ACL sample group for all three COL27A1 variants;
rs2567706 (A/G) CON vs. ACL (p = 0.623), CON vs. NON (p = 0.822); rs2241671 (G/A) CON
vs. ACL (p = 0.787), CON vs. NON (p = 0.751); rs2567705 (A/T) CON vs. ACL (p = 0.762),
CON vs. NON (p = 0.504) (S6 Table).
Haplotypes were inferred using the genotype data from the three investigated COL27A1
variants, rs2567706 (A/G), rs2241671 (G/A) and rs2567705 (A/T). No significant differences
in the distribution of the inferred haplotypes constructed from all COL27A1 variants were
noted between the control and case participants in the Achilles tendinopathy (p = 0.636)
(Figure A in S2 File) and ACL rupture sample groups (CON vs. ACL: p = 0.234, CON vs.
NON: p = 0.089) (Figure B in S2 File). Similar results were observed when male participants in
the ACL rupture sample group were evaluated independently (CON vs. ACL: p = 0.211, CON
vs. NON: p = 0.845) (Figure C in S2 File).
Discussion
Currently, our understanding of the biological mechanisms underpinning musculoskeletal
soft tissue injuries is limited. Consequently, only a select number of genes have been priori-
tised for exploration and only variants presented in the literature as being associated with
biological processes proposed to be involved in musculoskeletal soft tissue injuries, have
been investigated. To date, no more than 80 variants have been profiled in musculoskeletal
disorder association studies, which have had varying levels of replication success [2]. These
studies have predominantly used an a priori hypothesis driven, candidate variant approach.
However, it is unlikely that all risk modifying loci, predisposing for these complex, multifac-
torial conditions will be identified using this method alone. It is for this reason, that this
study adopted a multifaceted approach, whereby previous experimental research was used to
guide a targeted analysis of the WES data. Genes previously implicated in injury susceptibil-
ity were prioritised during the initial data mining steps and novel candidate variants were
prioritised for analysis based on allele frequency differences in the WES data between
sequenced controls and cases, putative functional and coding effects and population
frequencies.
The exome sequencing of 20 exemplar controls and cases identified 199 456 high quality
variants, 4544 of which demonstrated an allele frequency difference of� 30% between the
sequenced controls and cases. Interestingly, only 19 (<1%) variants meeting the allele fre-
quency threshold mapped to the genes previously implicated in the aetiology of Achilles
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tendinopathy. The majority of these variants localised to the neighbouring TNC and COL27A1
genes and were prioritised for further interrogation in this study.
The TNC gene encodes a hexameric extracellular matrix glycoprotein that is highly expressed
during embryonic development and in tissues subjected to tensile loading, including tendons
and ligaments. Moreover, transient expression is observed during wound healing, tissue remod-
elling and more persistently in pathological conditions [34–37]. Analysis of the TNC WES data
highlighted three tagged loci including, rs944510 (C/T), rs2992147 (T/C) and rs1061494 (T/C)
respectively. The missense rs1061494 variant served as a proxy for the other tagged loci. The
CC genotype of the rs1061494 variant, which is located within the first constitutively expressed
fibronectin type III (FNIII) repeat domain of the peptide, inferred a 2.5-fold increased risk for
chronic Achilles tendinopathy.
Recently, variants within the TNC gene have been acknowledged as expression quantitative
trait loci (eQTL) [38,39]. By definition, these are common variants in the genome that deter-
mine phenotypic traits including, alterations in transcript levels (eQTL) and protein abun-
dance (pQTL) [40,41]. Interestingly, rs1061494 is a predicted cis-eQTL in testis tissue,
whereby the CC genotype is predicted to associate with increased expression [42]. In the cur-
rent study, the CC genotype was overrepresented in the cases with Achilles tendinopathy, sug-
gesting potential increased TNC expression in the affected group. However, whether these
transcript-altering properties of rs1061494 in testis tissue translate to expression alterations in
dense connective tissue, requires experimental validation.
Another noteworthy finding pertained to the HSPG2 gene, encoding the perlecan modular
proteoglycan [43]. This gene demonstrated the greatest density of variants meeting the allele
frequency difference threshold. Interestingly, perlecan is a known biological substrate of tenas-
cin-C, with binding sites in the FNIII repeat domains [34]. Therefore, it can be hypothesised
that the concentration of variants within binding site sequences may alter the ability of these
two proteins to bind, thereby impacting matrix regulation and modulating susceptibility to
injury.
In addition, this study identified a risk-associated haplotype spanning 37.8kb (chronic
Achilles tendinopathy) across the TNC gene (Fig 6). Specifically, the inferred TNC T-T haplo-
type (rs1061494-rs2104772) was associated with decreased risk for chronic Achilles tendinopa-
thy. Both variants have independently been associated with risk for Achilles tendinopathy,
Fig 6. Risk-associated inferred haplotypes mapping to the TNC genomic interval. Diagram demonstrates two overlapping TNC inferred haplotypes
associated with the risk of musculoskeletal soft tissue injuries including Achilles tendinopathy (rs1061494-rs2104772) and recurrent rotator cuff injuries
(rs1138545-rs2104772-rs10759752) [6]. The genomic boundaries of TNC are provided according to the Human GRCh38.p10 genome release.
Translation of mRNA starts in exon 2 demonstrated by double dash. Although the genomic coordinates are provided in the 5’ to 3’ direction, the TNC
gene is orientated on the antisense strand. Black bars: Exons. Horizontal lines: Introns. Diagram not drawn to scale.
https://doi.org/10.1371/journal.pone.0205860.g006
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rs1061494 in the current study and rs2104772 in a previous study by Saunders et al. (2012)
[26]. Moreover, rs2104772 maps within 2kb of a guanine-thymine dinucleotide repeat, the first
variant proposed as a risk modifier for Achilles tendon injuries [18].
Interestingly, a novel three variant TNC inferred haplotype, C-A-G (rs1138545-rs2104772-
rs10759752), was recently associated with the risk of large recurrent defects after rotator cuff
surgery (Fig 6) [6]. The missense rs1138545 variant, described by the authors as the most influ-
ential marker of those associated, is located one amino acid away from the bridging sequence
between the FNIII (5) repeat and FNIII (1A) repeat domains [5]. Furthermore, rs1138545 is in
complete LD with rs7021589, a predicted cis-pQTL (protein quantitative trait loci) with signifi-
cant regulatory effects on protein plasma levels [39]. These results reiterate locus heterogeneity
among clinically distinct musculoskeletal soft tissue injuries, whereby some modifiers may be
common to the predisposing genetic signatures, while other motifs are unique.
Taken collectively, the proposed biological functions of these variants, together with the
data from the current and previous associations studies, provides support for the potential sig-
nificance of this genomic interval in the profile predisposing for injury [5,6,26]. It must be
noted that a deviation from HWE was observed for the rs1061494 and rs2104772 variants in
the respective control groups. This may be due to the highly selective inclusion criteria of
the control participants, which results in a group that is not representative of the general popu-
lation but represents a subset of the population at a divergent end of the injury phenotype
spectrum.
Approximately 800kb upstream from the associated TNC haplotype is the COL27A1 gene.
COL27A1 has previously been associated with the risk of Achilles tendinopathy, specifically
the rs946053 (T/G) variant in combination with other TNC variants [26]. The COL27A1
gene encodes the α1 chain of type XXVII collagen, an atypical member of the fibrillar collagen
family. The function of this protein family involves providing structural support and tensile
strength to extracellular matrices, with COL27A1 expression predominantly localised to carti-
laginous structures [44]. Analysis of the WES data identified four non-synonymous variants
in high linkage disequilibrium within COL27A1 namely rs2567707 (G/A), rs2567706 (A/G),
rs2808770 (T/C) and rs2808771 (C/T). The rs2567706 variant demonstrated the strongest pair-
wise linkage and for this reason, served as a proxy for the other tagged loci. However, in addi-
tion to rs2567706, no COL27A1 variants were significantly associated with the risk of chronic
Achilles tendinopathy or acute ACL ruptures.
According to the Sorting Intolerant from Tolerant (SIFT) [45] and Polymorphism pheno-
typing (Polyphen-2 v2) [46] online tools, none of the investigated variants were predicted to
be damaging in effect (Table 2). Conversely, according to the Combined Annotation Depen-
dent Depletion (CADD) framework for estimating the pathogenicity of genetic variation, the
TNC rs2104772 and rs1138545 variants in addition to the COL27A1 rs2567705 variant demon-
strated CADD_phred scores>13, equivalent to a 95% probability that the variant has an effect
functionally [47]. Similarly, the Fathmm_MKL tool for predicting the functional consequence
of coding and non-coding single nucleotide variants, predicted the rs2104772 variant to be
‘deleterious’ [48].
These results suggest that although not disease causing, the effects of these variants may be
impressionable at the functional level. Taking this into consideration, together with the high
prevalence of musculoskeletal soft tissue injuries, it is reasonable to hypothesise that these inju-
ries are underpinned by a myriad of common, non-lethal variants, each of which contribute
modestly to the molecular signature predisposing for injury. Another point to consider is that
although this study supports the involvement of genetics in the biology of musculoskeletal
soft tissue injuries, the intrinsic mechanisms resulting in injury are still not fully understood.
Therefore, the level to which these loci contribute to a connective tissue’s ability to respond to
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load or its ability to adapt and resolve after repetitive stressors is still unknown. Therefore, in
addition to prospective longitudinal risk factor analyses, the functional impact of these genetic
variants within the cellular environment also needs to be explored.
Furthermore, it is evident from the number of variants identified through WES in relation
to the number mapping to previously implicated genes, that much of the genome remains
uncharacterised in the aetiology of common sporting injuries. In saying this, it is likely that
many genes within the genome do not contribute to the aetiology of musculoskeletal injuries
and therefore, do not confer risk. However, it is also plausible to assume that variants, cur-
rently of unknown location and function, possess important risk modifying capabilities.
Therefore, these results support the need for further interrogation of the genome using multi-
integrated approaches.
Exome sequencing has an important limitation in that it overlooks the potential effects of
variants in intronic and regulatory regions of the gene. Furthermore, although this study made
use of highly selected exemplar controls and cases, the small number of sequenced individuals
means that important risk modifiers may have gone undetected. The size of the Achilles tendi-
nopathy sample group also presented as a limitation, in addition to that of the female ACL sub-
group. It is widely accepted that females are more predisposed to ACL ruptures, therefore it
would be of interest to focus recruitment efforts on obtaining more female participants for
future investigations. Future studies should aim to replicate these findings in other larger,
independent populations in addition to the samples collected through the Genomics of injuries
(GOINg) Consortium [49]. It is imperative that we facilitate in-depth explorations of the
genome to identify risk-conferring variants, a process that is more likely to be accomplished
through combining expertise and resources.
Conclusions
These results provided proof of concept for the use of a customised analysis pipeline, together
with a tiered filtering strategy, to explore a larger genomic dataset generated by WES. Due to
financial constraints preventing the high throughput sequencing of a large sample of individu-
als, selection of exemplar controls and cases was an important project objective. Although the
initial step of variant prioritisation was not based on statistical methods but rather a predeter-
mined allele frequency difference threshold, the potential biological significance of the candi-
date variants was an important consideration. Using this approach, this study has identified a
Table 2. Predicted functional effects of the TNC and COL27A1 variants prioritised for investigation after whole exome sequencing.
SNP ID Coding effect Functional effect predicted by
SIFT PolyPhen-2 CADD DANN Fathmm_MKL
TNC variants
rs1061494 NON-SYN T B 0.62 0.54 N
rs1138545 NON-SYN T B 17.19 0.85 N
rs2104772 NON-SYN T B 17.21 0.70 D
rs1061495 SYN - - - - -
COL27A1 variants
rs2567706 NON-SYN T B 2.00 0.81 N
rs2241671 NON-SYN T B 0.00 0.36 N
rs2567705 NON-SYN T B 16.51 0.91 N
SNP ID: dbSNP accession number. Coding effect: NON-SYN (non-synonymous); SYN (synonymous). T: Tolerated; B: Benign; D: Deleterious; N: Neutral. Bold typeset
indicates an estimate predicting for functional significance.
https://doi.org/10.1371/journal.pone.0205860.t002
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potential risk-modifying motif within the TNC gene for Achilles tendinopathy. Importantly, a
change in the pattern of tenascin-C expression is documented in pathological tendons, a par-
ticularly significant observation owing to its strong ability to modulate cell behaviour.
Therefore, knowledge of the underpinning genetic signatures may assist in defining the
multifactorial profiles predisposing for musculoskeletal soft tissue injuries. Although large pro-
spective follow-up studies will be required to evaluate the efficacy of genetic screens to accu-
rately predict injury risk, it is plausible to assume that this information may eventually be used
by clinicians to develop personalised injury reduction and prehabilitation programmes tar-
geted at strengthening tendons and ligaments.
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Frequency distribution of the inferred haplotypes constructed from the TNC rs1061494,
rs1138545, rs2104772 and rs1061495 variants in the ACL rupture sample group. (B) Frequency
distribution of the inferred haplotypes constructed from the TNC rs1061494 and rs2104772
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types constructed from the TNC rs1061494, rs1138545, rs2104772 and rs1061495 variants in
the male ACL rupture subgroup. (D) Frequency distribution of the inferred haplotypes con-
structed from the TNC rs1061494 and rs2104772 variants in the male ACL rupture subgroup.
CON: Control participants; ACL: Cases with ACL ruptures; NON: Cases reporting a non-con-
tact mechanism of injury. Statistically significant differences in haplotype frequency between
the groups are depicted on the graph, with p-values adjusted for age and weight and sex when
all participants were evaluated. The number of participants (n) in each group is in parentheses.
(TIF)
S2 File. Frequency distribution of COL27A1 haplotypes in the Achilles tendinopathy and
ACL rupture sample groups. Frequency distribution of the inferred haplotypes constructed
from the COL27A1 rs2567706, rs2241671 and rs2567705 variants in the (A) Achilles tendino-
pathy and (B) ACL rupture sample groups, in addition to the (C) male ACL rupture subgroup.
CON: Control participants; ACL: Cases with ACL ruptures; NON: Cases reporting a non-con-
tact mechanism of injury. Statistically significant differences in haplotype frequency between
the groups are depicted on the graph, with p-values adjusted for age and sex in the Achilles ten-
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rs1061495 on the physiological characteristics of participants. Values expressed as p-values.
Effects on weight and BMI are adjusted for age and sex. Effects on height are adjusted for sex.
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tively. P-values are for difference in genotypes and minor allele frequencies between diagnostic
groups adjusted for age at the time of recruitment for controls and at the time of injury for
cases, in addition to sex. Bold typeset indicates significance (p<0.05). Participant count for
genotypes presented in parenthesis and total count in italics. a rs1138545 CC genotype vs.
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